Vyepti® (eptinezumab-jjmr)
for Migraine

Vyepti (eptinezumab-jjmr) is an IV infusion given every 3 months to prevent chronic and episodic migraines in adults. It works by blocking CGRP, a protein that rises during migraine attacks and may trigger migraines. By targeting CGRP, Vyepti helps reduce the number of monthly migraine days and increase migraine-free days.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Migraine